期刊的影响因子--文章列表

期刊文章列表
Changjun Lv¹，Minghui Sun²，Yilei Guo¹，Wenxin Xia¹，Simiao Qiao¹，Yu Tao¹，Yulai Fang¹，Qin Zhang¹，Yanrong Zhu¹，Yusufu Yalikun²，Yufeng Xia¹，Zhifeng Wei¹，Yue Dai¹（Department of Pharmacology of Chinese Materia Medica，School of Traditional Chinese Pharmacy，China Pharmaceutical University；Division of Sports Medicine and Adult Reconstructive Surgery，Department of Orthopedic Surgery，Nanjing Drum Tower Hospital，the Affiliated Hospital of Nanjing University Medical School）.Cholinergic dysfunction-induced insufficient activation of alpha7 nicotinic acetylcholine receptor drives the development of rheumatoid arthritis through promoting protein citrullination via the SP3/PAD4 pathway[J].Acta Pharmaceutica Sinica B,2023,第4期 Xiaoqing Liu，Shuang Liang，Xiao Sang，Lili Chang，Shunli Fu，Han Yang，Huizhen Yang，Yongjun Liu，Na Zhang（Department of Pharmaceutics，Key Laboratory of Chemical Biology（Ministry of Education），NMPA Key Laboratory for Technology Research and Evaluation of Drug Products，School of Pharmaceutical Sciences，Cheeloo College of Medicine，Shandong University）.On-demand integrated nano-engager converting cold tumors to hot via increased DNA damage and dual immune checkpoint inhibition[J].Acta Pharmaceutica Sinica B,2023,第4期 Zhimei Xing^1,2，Han Gao^1,3，Dan Wang^1,2，Ye Shang^1,2，Tenukeguli Tuliebieke^1,2，Jibao Jiang⁴，Chunxiao Li^1,2，Hong Wang¹，Zhenguo Li⁵，Lifu Jia⁶，Yongsheng Wu⁵，Dandan Wang⁵，Wenzhi Yang^1,2，Yanxu Chang^1,2，Xiaoying Zhang^1,2，Liuwei Xu^1,2，Chao Jiang⁷，Luqi Huang⁷，Xiaoxuan Tian^1,2（State Key Laboratory of Component-Based Chinese Medicine，Tianjin University of Traditional Chinese Medicine；Haihe Laboratory of Modern Chinese Medicine；Jiangsu Key Laboratory for Biodiversity and Biotechnology，College of Life Sciences，Nanjing Normal University；School of Agriculture and Biology，Shanghai Jiao Tong University；Mudanjiang YouBo Pharmaceutical Co.Ltd.；Guizhou Ruihe Pharmaceutical Co.Ltd.；State Key Laboratory of Dao-di Herbs，National Resource Center for Chinese Materia Medica，China Academy of Chinese Medical Sciences）.A novel biological sources consistency evaluation method reveals high level of biodiversity within wild natural medicine：A case study of Amynthas earthworms as "Guang Dilong"[J].Acta Pharmaceutica Sinica B,2023,第4期 Yuyu Liu，Xinnan Li，Songyang Sui，Jingshu Tang，Dawei Chen，Yuying Kang，Kebo Xie，Jimei Liu，Jiaqi Lan，Lei Wu，Ridao Chen，Ying Peng，Jungui Dai（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs，and NHC Key Laboratory of Biosynthesis of Natural Products，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College）.Structural diversification of bioactive bibenzyls through modular co-culture leading to the discovery of a novel neuroprotective agent[J].Acta Pharmaceutica Sinica B,2023,第4期 Yichen Zhong^1,2，Shi Du^1,2，Yizhou Dong^1,3,2（Division of Pharmaceutics & Pharmacology，College of Pharmacy，The Ohio State University；Icahn Genomics Institute，Precision Immunology Institute，Department of Oncological Sciences，Tisch Cancer Institute，Friedman Brain Institute，Icahn School of Medicine at Mount Sinai；Department of Radiation Oncology，Department of Biomedical Engineering，Center for Clinical and Translational Science，Comprehensive Cancer Center，Dorothy M. Davis Heart & Lung Research Institute，Center for Cancer Engineering，Center for Cancer Metabolism，Pelotonia Institute for Immune-Oncology，The Ohio State University）.mRNA delivery in cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2023,第4期 Yan Shi¹，Candy Lee²，Peng Sang¹，Zaid Amso²，David Huang²，Weixia Zhong²，Meng Gu¹，Lulu Wei¹，Van T.B.Nguyen-Tran²，Jingyao Zhang¹，Weijun Shen²，Jianfeng Cai¹（Department of Chemistry，University of South Florida；Calibr at Scripps Research）.α/Sulfono-γ-AA peptide hybrids agonist of GLP-1R with prolonged action both in vitro and in vivo[J].Acta Pharmaceutica Sinica B,2023,第4期 Yixiang Xu¹，Chao Zhang¹，Kai Jiang²，Xinchun Yang³，Feng Chen²，Zhiyang Cheng²，Jinlong Zhao³，Jiaxing Cheng³，Xiaokang Li¹，Xin Chen¹，Luoyifan Zhou¹，Hao Duan¹，Yunyuan Huang⁴，Yaozu Xiang²，Jian Li^1,5,6,7（State Key Laboratory of Bioreactor Engineering，Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism，Frontiers Science Center for Materiobiology and Dynamic Chemistry，Shanghai Key Laboratory of New Drug Design，School of Pharmacy，East China University of Science and Technology；Shanghai East Hospital，School of Life Sciences and Technology，Tongji University；East China University of Science and Technology-Tengbai Pharmaceutical Innovative Drugs Joint Research Institute，Zhuhai Tengbai Pharmaceutical Co.，Ltd.；Hubei Key Laboratory of Genetic Regulation and Integrative Biology，School of Life Sciences，Central China Normal University；Yunnan Key Laboratory of Screening and Research on Anti-pathogenic Plant Resources from West Yunnan，College of Pharmacy，Dali University；Clinical Medicine Scientific and Technical Innovation Center，Shanghai Tenth People's Hospital，Tongji University School of Medicine；Key Laboratory of Tropical Biological Resources of Ministry of Education，College of Pharmacy，Hainan University）.Structural repurposing of SGLT2 inhibitor empagliflozin for strengthening anti-heart failure activity with lower glycosuria[J].Acta Pharmaceutica Sinica B,2023,第4期 Yongxi Liang¹，Delin Min¹，Hulin Fan¹，Kunlin Liu¹，Juchuanli Tu²，Xueyan He²，Bingjie Liu²，Lu Zhou¹，Suling Liu²，Xun Sun^1,3（School of Pharmacy，Fudan University；Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences，State Key Laboratory of Genetic Engineering，Fudan University；The Institutes of Integrative Medicine of Fudan University）.Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer[J].Acta Pharmaceutica Sinica B,2023,第4期 Bo Jin¹，Xuechao Pang¹，Qingce Zang¹，Man Ga¹，Jing Xu¹，Zhigang Luo¹，Ruiping Zhang¹，Jiangong Shi¹，Jiuming He^1,2，Zeper Abliz^1,3,4（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；NMPA Key Laboratory for Safety Research and Evaluation of Innovative Drug；Key Laboratory of Mass Spectrometry Imaging and Metabolomics(Minzu University of China)，National Ethnic Affairs Commission；Key Laboratory of Ethnomedicine of Ministry of Education，School of Pharmacy，Minzu University of China）.Spatiotemporally resolved metabolomics and isotope tracing reveal CNS drug targets[J].Acta Pharmaceutica Sinica B,2023,第4期 Shaowei Bing^1,2，Senfeng Xiang²，Zhimei Xia²，Yilong Wang^1,3，Zhonghai Guan^1,3，Jinxin Che^2,4，Aixiao Xu²，Xiaowu Dong^2,5,4，Ji Cao^2,5,4，Bo Yang²，Jinhu Wang^1,5,3，Qiaojun He^2,5,4，Meidan Ying^1,2,5,3（Department of Surgical Oncology，Children's Hospital，Zhejiang University School of Medicine；Institute of Pharmacology and Toxicology，Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，College of Pharmaceutical Sciences，Zhejiang University；Pediatric Cancer Research Center，National Clinical Research Center for Child Health；Innovation Institute for Artificial Intelligence in Medicine，Zhejiang University；Cancer Center，Zhejiang University）.AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells[J].Acta Pharmaceutica Sinica B,2023,第4期 Ramya Dhandapani，Swaminathan Sethuraman，Uma Maheswari Krishnan，Anuradha Subramanian（Centre for Nanotechnology ＆ Advanced Biomaterials，School of Chemical ＆ Biotechnology，SASTRA Deemed University）.Self-assembled multifunctional nanotheranostics against circulating tumor clusters in metastatic breast cancer[J].Acta Pharmaceutica Sinica B,2023,第4期 Lu Su^1,2，Kellie S.Dalby¹，Hannah Luehmann³，Sussana A.Elkassih¹，Sangho Cho¹，Xun He¹，Lisa Detering³，Yen-Nan Lin¹，Nari Kang¹，Dennis A.Moore⁴，Richard Laforest³，Guorong Sun¹，Yongjian Liu³，Karen L.Wooley¹（Department of Chemistry，Department of Materials Science and Engineering，and Department of Chemical Engineering，Texas A&M University；Laboratory of Macromolecular and Organic Chemistry and Institute for Complex Molecular Systems，Eindhoven University of Technology；Mallinckrodt Institute of Radiology，Washington University School of Medicine；Bayer AG）.Ultrasmall, elementary and highly translational nanoparticle X-ray contrast media from amphiphilic iodinated statistical copolymers[J].Acta Pharmaceutica Sinica B,2023,第4期 Juan Pang¹，Jia Nuo Feng^2,3,4，Wenhua Ling¹，Tianru Jin^2,3,4（Division of Nutrition，School of Public Health，Sun Yat-sen University；Banting and Best Diabetes Centre，Faculty of Medicine，University of Toronto；Dept. of Physiology，University of Toronto；Division of Advanced Diagnostics，Toronto General Hospital Research Institute，University Health Network）.Commentary：Can FXR serve as a potential target for COVID-19 prevention?[J].Acta Pharmaceutica Sinica B,2023,第4期 Wei Tao（Center for Nanomedicine and Department of Anesthesiology，Brigham and Women’s Hospital，Harvard Medical School）.Editorial of Special Column on RNA Therapeutics and Drug Delivery Technologies for Medical Applications[J].Acta Pharmaceutica Sinica B,2023,第4期 Sheng Chen^1,2，Tailin He²，Yiming Zhong²，Mingjue Chen²，Qing Yao²，Di Chen³，Zengwu Shao¹，Guozhi Xiao²（Department of Orthopaedics，Union Hospital，Tongji Medical College，Huazhong University of Science and Technology；Department of Biochemistry，School of Medicine，Shenzhen Key Laboratory of Cell Microenvironment，Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research，Southern University of Science and Technology；Research Center for Human Tissues and Organs Degeneration，Shenzhen Institutes of Advanced Technology，Chinese Academy of Sciences）.Roles of focal adhesion proteins in skeleton and diseases[J].Acta Pharmaceutica Sinica B,2023,第3期 Xingcai Zhang¹，Luo Hai²，Yibo Gao^2,3,4,5，Guocan Yu⁶，Yingli Sun^3,7,8（School of Engineering and Applied Sciences，Harvard University；Central Laboratory，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Thoracic Surgery，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；State Key Laboratory of Molecular Oncology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Laboratory of Translational Medicine，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology，Department of Chemistry，Tsinghua University；University of Chinese Academy of Sciences；CAS Key Laboratory of Genome Sciences and Information，Beijing Institute of Genomics，Chinese Academy of Sciences/China National Center for Bioinformation）.Lipid nanomaterials-based RNA therapy and cancer treatment[J].Acta Pharmaceutica Sinica B,2023,第3期 Mengnan Zhao¹，Rujing Wang¹，Kunmeng Yang²，Yuhong Jiang³，Yachen Peng^4,5，Yuke Li¹，Zhen Zhang¹，Jianxun Ding⁴，Sanjun Shi¹（State Key Laboratory of Southwestern Chinese Medicine Resources，School of Pharmacy，Chengdu University of Traditional Chinese Medicine；The First Norman Bethune College of Clinical Medicine，Jilin University；School of Life Science and Engineering，Southwest Jiaotong University；Key Laboratory of Polymer Ecomaterials，Changchun Institute of Applied Chemistry，Chinese Academy of Sciences；Department of Orthopedics，China-Japan Union Hospital of Jilin University）.Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis[J].Acta Pharmaceutica Sinica B,2023,第3期 Qian Zhou¹，Meiling Le¹，Yiyi Yang¹，Wenjuan Wang²，Yuqi Huang¹，Quan Wang¹，Yijing Tian¹，Meiyan Jiang¹，Yong Rao^2,3，Hai-Bin Luo^1,2,3，Yinuo Wu¹（School of Pharmaceutical Sciences，Sun Yat-sen University；Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute，School of Pharmaceutical Sciences，Hainan University；Song Li' Academician Workstation of Hainan University (School of Pharmaceutical Sciences)）.Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia：Suppression of neuroinflammation by blocking NF-κB transcription regulation and activating cAMP/CREB axis[J].Acta Pharmaceutica Sinica B,2023,第3期 Xiaoqing Fan，Chutian Mai，Ling Zuo²，Jumin Huang，Chun Xie^3,4,5，Zebo Jiang⁶，Runze Li⁷，Xiaojun Yao，Xingxing Fan，Qibiao Wu，Peiyu Yan，Liang Liu⁷，Jianxin Chen²，Ying Xie⁷，Elaine Lai-Han Leung^3,4,5（Dr.Neher’s Biophysics Laboratory for Innovative Drug Discovery，State Key Laboratory of Quality Research in Chinese Medicine，Macau University of Science and Technology；Beijing University of Chinese Medicine；Cancer Center；Faculty of Health Science；MOE Frontiers Science Center for Precision Oncology，University of Macau；Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging，the Fifth Affiliated Hospital，Sun Yat-sen University；State Key Laboratory of Dampness Syndrome of Chinese Medicine，the Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)）.Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice[J].Acta Pharmaceutica Sinica B,2023,第3期 Jiang Wu¹，Wenfeng Gou²，Zhiyun Wang³，Huajie Chang³，Deguan Li²，Wenbin Hou²，Changxiao Liu⁴（Department of Pharmaceutical Engineering，School of Chemical Engineering and Technology，Tianjin University；Institute of Radiation Medicine，Chinese Academy of Medical Sciences；School of Chinese Materia Medica，Tianjin University of Traditional Chinese Medicine；Research Center for New Drug Evaluation，the State Laboratory of Drug Delivery Technology and Pharmacokinetics，Tianjin Institute of Pharmaceutical Research）.Discovery of the radio-protecting effect of Ecliptae Herba,its constituents and targeting p53-mediated apoptosis in vitro and in vivo[J].Acta Pharmaceutica Sinica B,2023,第3期 Lei Zhang^1,2,3，Biwei Ye^1,3，Zhuo Chen^1,2,3，Zhe-Sheng Chen（State Key Laboratory of Structural Chemistry，Fujian Institute of Research on the Structure of Matter，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Fujian Agriculture and Forestry University；Department of Pharmaceutical Sciences，College of Pharmacy and Health Sciences，St.John’s University）.Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers[J].Acta Pharmaceutica Sinica B,2023,第3期 Tian-guang Zhang，Chao-yu Miao（Department of Pharmacology，Second Military Medical University/Naval Medical University）.Mitochondrial transplantation as a promising therapy for mitochondrial diseases[J].Acta Pharmaceutica Sinica B,2023,第3期 Yanfang Yang¹，Ke Feng²，Liying Yuan¹，Yuxin Liu¹，Mengying Zhang³，Kaimin Guo³，Zequn Yin⁴，Wenjia Wang³，Shuiping Zhou^5,6，He Sun^3,5,6，Kaijing Yan^3,5,6，Xijun Yan^5,6，Xuerui Wang⁴，Yajun Duan^4,7，Yunhui Hu³，Jihong Han^1,4（College of Life Sciences，State Key Laboratory of Medicinal Chemical Biology，Key Laboratory of Bioactive Materials of Ministry of Education，Nankai University；Department of Physiology，Binzhou Medical University；Cloudphar Pharmaceuticals Co.Ltd.；Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes，Hefei University of Technology；The State Key Laboratory of Core Technology in Innovative Chinese Medicine，Tasly Academy，Tasly Holding Group Co.Ltd.；Tasly Pharmaceutical Group Co.Ltd.；Department of Cardiology，the First Affiliated Hospital of USTC，Division of Life Science and Medicine，University of Science and Technology of China）.Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms[J].Acta Pharmaceutica Sinica B,2023,第3期 Sae-Bom Yoon^1,2，Hyowon Hong¹，Hee-Jong Lim¹，Ji Hye Choi¹，Yoon Pyo Choi³，Seong Wook Seo³，Hyuk Woo Lee³，Chong Hak Chae¹，Woo-Kyu Park¹，Hyun Young Kim¹，Daeyoung Jeong¹，Tran Quang De¹，Chang-Seon Myung²，Heeyeong Cho¹（Therapeutics & Biotechnology Division，Korea Research Institute of Chemical Technology；Department of Pharmacology，Chungnam National University College of Pharmacy；Future Medicine Co.Ltd.Rm616 LH-Business Growth Center）.A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway[J].Acta Pharmaceutica Sinica B,2023,第3期 Zhe Chen^1,2，Chaoyang Meng^1,3，Junhua Mai¹，Yongbin Liu¹，Hangwen Li⁴，Haifa Shen^1,5（Department of Nanomedicine，Houston Methodist Academic Institute；Xiangya Hospital of Central South University；Department of Hepatobiliary and Pancreatic Surgery，First Affiliated Hospital，Zhejiang University School of Medicine；Stemirna Therapeutics；Immuno Q Therapeutics）.An mRNA vaccine elicits STING-dependent antitumor immune responses[J].Acta Pharmaceutica Sinica B,2023,第3期 Zheng Zhou，Keying Li，Yongchao Chu，Chao Li，Tongyu Zhang，Peixin Liu，Tao Sun，Chen Jiang（Department of Pharmaceutics，School of Pharmacy，Fudan University，Key Laboratory of Smart Drug Delivery，Ministry of Education，State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science）.ROS-removing nano-medicine for navigating inflammatory microenvironment to enhance anti-epileptic therapy[J].Acta Pharmaceutica Sinica B,2023,第3期 Xing Duan¹，Yi Zhang²，Mengran Guo²，Na Fan¹，Kepan Chen¹，Shugang Qin¹，Wen Xiao¹，Qian Zheng¹，Hai Huang¹，Xiawei Wei¹，Yuquan Wei¹，Xiangrong Song¹（Department of Critical Care Medicine，Department of Clinical Pharmacy，Frontiers Science Center for Disease-related Molecular Network，State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Sichuan University；West China Hospital，Sichuan University）.Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine[J].Acta Pharmaceutica Sinica B,2023,第3期首页上一页 7 8 9 10 11 下一页尾页共有12页，转到页

期刊文章列表